Showing results (61-70 of 98) with videos related to
Sort By:
Pageof 10
NPJ Vaccines|August 22, 2020
A candidate vaccine for human visceral leishmaniasis based on a specific T cell epitope-containing chimeric protein protects mice against Leishmania infantum infectionDaniela P Lage, Patrícia A F Ribeiro, Daniel S Dias, et al.Cellular Immunology|August 23, 2020
A Leishmania amastigote-specific hypothetical protein evaluated as recombinant protein plus Th1 adjuvant or DNA plasmid-based vaccine to protect against visceral leishmaniasisJoão A Oliveira-da-Silva, Amanda S Machado, Fernanda F Ramos, et al.Parasitology International|December 2, 2025
Recombinant small myristoylated protein-3 and synthetic peptide as diagnostic and prognostic biomarkers for tegumentary leishmaniasisMaíza M Rodrigues, Raquel S B Câmara, Camila S Freitas, et al.Vaccines|July 27, 2022
A Recombinant Chimeric Protein-Based Vaccine Containing T-Cell Epitopes from Amastigote Proteins and Combined with Distinct Adjuvants, Induces Immunogenicity and Protection against Leishmania infantum InfectionDaniela P Lage, Danniele L Vale, Flávia P Linhares, et al.Pathogens (Basel, Switzerland)|December 31, 2025
Immunotherapeutics Combining a Recombinant Chimeric Protein, Monophosphoryl Lipid A, and Miltefosine Against Visceral LeishmaniasisMarcelo M Jesus, Daniela P Lage, Breno L Pimenta, et al.Research in Veterinary Science|August 16, 2019
Diagnostic markers selected by immunoproteomics and phage display applied for the serodiagnosis of canine leishmaniosisJuliana M Machado, Lourena E Costa, Daniel S Dias, et al.Experimental Parasitology|March 21, 2024
Treatment using vanillin-derived synthetic molecules incorporated into polymeric micelles is effective against infection caused by Leishmania amazonensis speciesIsabela A G Pereira, Camila S Freitas, Raquel S B Câmara, et al.Cytokine|February 19, 2024
New synthetic molecules incorporated into polymeric micelles used for treatment against visceral leishmaniasisCamila S Freitas, Isabela A G Pereira, Daniela P Lage, et al.Microbial Pathogenesis|December 9, 2021
Sensitive and specific serodiagnosis of tegumentary leishmaniasis using a new chimeric protein based on specific B-cell epitopes of Leishmania antigenic proteinsNathalia C Galvani, Amanda S Machado, Daniela P Lage, et al.Experimental Parasitology|June 25, 2025
Urine- and serum-based ELISA using a new recombinant chimeric protein to diagnose tegumentary and visceral leishmaniasis: a preliminary studyRaquel S B Câmara, Ana L Silva, Camila S Freitas, et al.Pageof 10